Sanofi (LON:0A2V)

Sanofi Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15,359	7,441	8,710	12,736	10,098	13,915
Trading Asset Securities	-	115	112	146	11	-
Cash & Short-Term Investments	15,359	7,556	8,822	12,882	10,109	13,915
Cash Growth	126.03%	-14.35%	-31.52%	27.43%	-27.35%	47.55%
Accounts Receivable	7,810	7,677	8,433	8,424	7,568	7,491
Other Receivables	397	2,952	2,607	2,323	2,219	2,462
Receivables	8,207	10,629	11,040	10,747	9,787	9,953
Inventory	9,618	9,431	9,666	8,960	8,715	8,352
Prepaid Expenses	-	895	768	714	615	525
Other Current Assets	3,833	14,077	374	808	1,427	1,041
Total Current Assets	37,017	42,588	30,670	34,111	30,653	33,786
Property, Plant & Equipment	11,007	11,601	11,814	11,684	11,976	10,563
Long-Term Investments	6,995	3,259	2,666	2,765	2,422	2,105
Goodwill	40,283	43,384	49,404	49,892	48,056	44,364
Other Intangible Assets	12,383	14,260	18,281	15,414	13,677	12,249
Long-Term Deferred Tax Assets	8,008	7,967	6,427	5,381	4,598	4,176
Long-Term Deferred Charges	8,048	8,369	6,038	6,226	7,730	6,092
Other Long-Term Assets	836	868	573	797	645	541
Total Assets	124,959	132,798	126,464	126,722	120,242	114,413
Accounts Payable	7,075	7,551	7,328	6,813	6,180	5,295
Accrued Expenses	-	2,366	2,501	2,578	2,554	2,389
Short-Term Debt	139	200	203	164	189	285
Current Portion of Long-Term Debt	7,170	4,016	1,843	4,010	2,995	2,482
Current Portion of Leases	252	261	275	277	269	232
Current Income Taxes Payable	724	697	597	574	309	604
Current Unearned Revenue	-	-	-	269	321	252
Other Current Liabilities	13,699	14,071	11,460	9,289	8,478	7,741
Total Current Liabilities	29,059	29,162	24,207	23,974	21,295	19,280
Long-Term Debt	13,200	11,791	14,347	14,857	17,123	19,745
Long-Term Leases	1,524	1,645	1,755	1,904	1,839	931
Long-Term Deferred Tax Liabilities	1,715	2,166	1,857	1,841	1,617	1,770
Other Long-Term Liabilities	7,477	8,185	7,731	6,955	6,390	6,159
Total Liabilities	54,680	54,941	52,111	51,570	51,211	51,161
Common Stock	2,456	2,526	2,530	2,522	2,527	2,518
Additional Paid-In Capital	11	-	313	125	532	362
Treasury Stock	-975	-840	-1,184	-706	-939	-705
Comprehensive Income & Other	68,516	75,821	72,381	72,843	66,561	60,931
Total Common Equity	70,008	77,507	74,040	74,784	68,681	63,106
Minority Interest	271	350	313	368	350	146
Shareholders' Equity	70,279	77,857	74,353	75,152	69,031	63,252
Total Liabilities & Equity	124,959	132,798	126,464	126,722	120,242	114,413
Total Debt	22,285	17,913	18,423	21,212	22,415	23,675
Net Cash (Debt)	-6,926	-10,357	-9,601	-8,330	-12,306	-9,760
Net Cash Per Share	-5.57	-8.25	-7.64	-6.63	-9.78	-7.75
Filing Date Shares Outstanding	1,217	1,254	1,249	1,249	1,249	1,249
Total Common Shares Outstanding	1,217	1,254	1,251	1,253	1,253	1,251
Working Capital	7,958	13,426	6,463	10,137	9,358	14,506
Book Value Per Share	57.52	61.83	59.17	59.70	54.83	50.46
Tangible Book Value	17,342	19,863	6,355	9,478	6,948	6,493
Tangible Book Value Per Share	14.25	15.84	5.08	7.57	5.55	5.19
Land	-	201	228	237	240	236
Buildings	-	7,444	7,681	7,328	7,170	6,828
Machinery	-	12,843	13,412	13,363	14,303	13,651
Construction In Progress	-	3,573	3,449	2,996	3,097	2,454

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.